🟢 Marker Therapeutics is trading 6% up; no catalyst identified

Marker Therapeutics is trading at $1.03, up 6.01%, with the gain unexplained.

• No October 12 company-specific catalyst was identified; the investor-relations page lists September 22 as the latest press release.
• Major indexes were mixed and did not show a greater-than-0.5% move in the same direction as the shares, so the evidence does not establish a broad-market explanation.
• There is no evidence tying the gain to the earlier manufacturing update.